GEHC 📈 GE HealthCare Technologies - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US36266G1076
GEHC: Imaging Machines, Ultrasound Devices, Patient Monitoring Systems, Diagnostic Agents
GE HealthCare Technologies Inc. is a leading developer, manufacturer, and marketer of medical products, services, and digital solutions that cater to the diagnosis, treatment, and monitoring of patients globally. The company's operations are divided into four distinct segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. Each segment offers a unique set of products and services that cater to specific needs in the healthcare industry. For instance, the Imaging segment provides a range of products, including molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, and X-ray systems, which are essential for accurate diagnoses and treatments. Additionally, this segment also offers image-guided therapy and women's health products, which are critical in providing comprehensive care to patients.
The Ultrasound segment is another vital part of GE HealthCare Technologies Inc., providing medical devices and solutions for various clinical areas, such as radiology, primary care, women's health, and cardiovascular care. The segment's products include point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products, which enable healthcare professionals to make informed decisions and provide effective care. The Patient Care Solutions segment, on the other hand, offers a broad portfolio of medical devices, consumables, services, and digital solutions, including patient monitoring solutions, anesthesia delivery and respiratory care products, and maternal infant care products. This segment's products and services are designed to support healthcare professionals in providing high-quality patient care.
The Pharmaceutical Diagnostics segment supplies diagnostic agents, including contrast media pharmaceuticals and molecular imaging agents, to the radiology and nuclear medicine industry. These agents are used to increase the visibility of tissues or structures during imaging exams, enabling healthcare professionals to make accurate diagnoses and develop effective treatment plans. Furthermore, the company has collaborated with Mass General Brigham to leverage artificial intelligence (AI) in its operations, which is expected to enhance its product offerings and services. With its headquarters in Chicago, Illinois, and a global presence, GE HealthCare Technologies Inc. is well-positioned to drive innovation and growth in the healthcare industry.
As a publicly traded company, GE HealthCare Technologies Inc. is committed to delivering value to its shareholders while providing innovative solutions to the healthcare industry. The company's common stock is listed on the NASDAQ stock exchange, and its operations are guided by a strong commitment to quality, innovation, and customer satisfaction. With a web presence at https://www.gehealthcare.com, the company provides easy access to information about its products, services, and operations, making it a transparent and accountable player in the healthcare industry. The company's ISIN, US36266G1076, and GICS Sub Industry classification as Health Care Equipment, further underscore its focus on providing specialized equipment and solutions to the healthcare sector.
Additional Sources for GEHC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
GEHC Stock Overview
Market Cap in USD | 37,052m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 2023-01-04 |
GEHC Stock Ratings
Growth 5y | 47.8% |
Fundamental | 55.6% |
Dividend | 35.1% |
Rel. Strength Industry | -7.66 |
Analysts | 4.05/5 |
Fair Price Momentum | 69.13 USD |
Fair Price DCF | 95.98 USD |
GEHC Dividends
Dividend Yield 12m | 0.15% |
Yield on Cost 5y | 0.20% |
Annual Growth 5y | 15.47% |
Payout Consistency | 100.0% |
GEHC Growth Ratios
Growth Correlation 3m | -96% |
Growth Correlation 12m | 25.4% |
Growth Correlation 5y | 61.8% |
CAGR 5y | 14.68% |
CAGR/Mean DD 5y | 1.38 |
Sharpe Ratio 12m | 0.05 |
Alpha | -22.32 |
Beta | 0.92 |
Volatility | 25.88% |
Current Volume | 11179.9k |
Average Volume 20d | 3343.8k |
As of December 21, 2024, the stock is trading at USD 78.91 with a total of 11,179,862 shares traded.
Over the past week, the price has changed by -2.70%, over one month by -7.06%, over three months by -12.57% and over the past year by +4.75%.
Partly, yes. Based on ValueRay Fundamental Analyses, GE HealthCare Technologies (NASDAQ:GEHC) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 55.60 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GEHC as of December 2024 is 69.13. This means that GEHC is currently overvalued and has a potential downside of -12.39%.
GE HealthCare Technologies has received a consensus analysts rating of 4.05. Therefor, it is recommend to buy GEHC.
- Strong Buy: 10
- Buy: 3
- Hold: 6
- Sell: 0
- Strong Sell: 1
According to ValueRays Forecast Model, GEHC GE HealthCare Technologies will be worth about 75.8 in December 2025. The stock is currently trading at 78.91. This means that the stock has a potential downside of -3.99%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 96.8 | 22.7% |
Analysts Target Price | 88 | 11.5% |
ValueRay Target Price | 75.8 | -4% |